Healthcare & pharmaceutical equity investment research - Page 2

Healthcare Insights

Market cap

Date (published)

thematic

Healthcare

13.11.23

VolitionRx – Decoding the DNA of cancer

thematic

Healthcare

04.01.24

Outlook for 2024: Life sciences – where has the conviction gone?

Healthcare

thematic

11.11.24

Healthcare-focused trusts: A sector on the mend

Latest

Healthcare | Non client QV

20.01.25

Herantis Pharma — Potential disease-modifier for PD

Healthcare | Update

17.01.25

Newron Pharmaceuticals — Spotlight on evenamide following licensing deals

Healthcare | Outlook

15.01.25

Immix Biopharma — Shifting the ALA treatment paradigm with CAR-T

Healthcare | Update

03.01.25

Mendus — Regulatory endorsement supports vididencel focus

insight

Healthcare

25.05.23

An update on OpGen: Deals, expansion and revenues

insight

Healthcare

18.05.23

Volition: Views from the sharp end

insight

Healthcare

18.05.23

Incannex Healthcare: Data opens path to treat anxiety

insight

Healthcare

09.02.23

February 2023 Edition of Edison Healthcare Insight

insight

Healthcare

30.01.23

VolitionRx: Commercializing the Nu.Q Vet Cancer Test: Webinar

insight

Healthcare

20.12.22

Encouraging top-line data from Unyvero urinary tract infection (UTI) panel

Equities

Region

Market cap

Nykode Therapeutics (NYKD)

Latest price

NOK2.62

▾ −0.01 (−0.38)

As at 21/01/2025

Market capitalisation: NOK878m

View equity

QuickView

Healthcare

09.12.24

Nykode Therapeutics — Repositioned to streamline clinical progress

See more
content on

Nykode Therapeutics

OpGen (OPGN)

Latest price

USD1.16

▾ −0.57 (−32.95)

As at 21/01/2025

Market capitalisation: USD18m

View equity

Update

Healthcare

14.08.23

OpGen — Cash concerns dampen active Q2

Flash note

Healthcare

04.08.23

OpGen — FIND collaboration advances to development

Flash note

Healthcare

21.07.23

OpGen — Feasibility milestone from FIND collaboration

See more
content on

OpGen

Oryzon Genomics (ORY)

Latest price

EUR1.47

▾ 0.02 (1.10)

As at 21/01/2025

Market capitalisation: EUR97m

View equity

Update

Healthcare

30.10.24

Oryzon Genomics — Q3 results recap key upcoming inflection points

Flash note

Healthcare

02.10.24

Oryzon Genomics — FDA aligns on Phase III BPD plans

Update

Healthcare

23.09.24

Oryzon Genomics — Final PORTICO data reaffirms potential in BPD

See more
content on

Oryzon Genomics

OSE Immunotherapeutics (OSE)

Latest price

EUR6.56

▾ 0.01 (0.15)

As at 21/01/2025

Market capitalisation: EUR147m

View equity

Update

Healthcare

21.11.24

OSE Immunotherapeutics — Full Lusvertikimab results reflect potential in UC

Update

Healthcare

09.10.24

OSE Immunotherapeutics — Riding the H124 tailwinds

Flash note

Healthcare

11.09.24

OSE Immunotherapeutics — Tedopi registrational study commences

See more
content on

OSE Immunotherapeutics

Percheron Therapeutics (PER)

Latest price

GBP0.00

— 0.00 (−11.11)

As at 21/01/2025

Market capitalisation: GBP10m

View equity

Recce Pharmaceuticals (RCE)

Latest price

AUD0.48

▾ 0.01 (2.13)

As at 21/01/2025

Market capitalisation: AUD109m

View equity

Flash note

Healthcare

17.12.24

Recce Pharmaceuticals — BPOM clearance to start Phase III R327G study

Update

Healthcare

02.12.24

Recce Pharmaceuticals — Topical R327G approaching pivotal stages

Update

Healthcare

11.07.24

Recce Pharmaceuticals — Taking a closer look at diabetic foot infections

See more
content on

Recce Pharmaceuticals

Sareum Holdings (SAR)

Latest price

GBP0.23

▾ 0.50 (2.22)

As at 21/01/2025

Market capitalisation: GBP28m

View equity

Update

Healthcare

12.11.24

Sareum Holdings — SDC-1801 prepping to enter Phase II

Update

TMT

28.10.24

Freelancer — Escrow drives strong volume growth in Q324

Flash note

Healthcare

11.10.24

Sareum Holdings — New funding extends runway to Phase II

See more
content on

Sareum Holdings

SIGA Technologies (SIGA)

Latest price

USD6.32

▾ 0.10 (1.53)

As at 21/01/2025

Market capitalisation: USD445m

View equity

Update

Healthcare

18.11.24

SIGA Technologies — Strong order book moving into Q424

Flash note

Healthcare

23.08.24

SIGA Technologies — TPOXX chalks up another DoD contract win

Flash note

Healthcare

19.08.24

SIGA Technologies — PALM 007 data warrant a closer look in mpox

See more
content on

SIGA Technologies

Curated by Edison

singularityhub.com

The Next Step for AI in Biology Is to Predict How Proteins Behave in the Body

Healthcare

A new protein atlas can help turn static AI predictions of protein shapes into more fluid predictions of how proteins behave in the body.

Read article

www.genome.gov

The Cost of Sequencing a Human Genome

Healthcare

Estimated cost of sequencing the human genome over time since the Human Genome Project.

Read article

www.prnewswire.com

J.P. Morgan Launches New Life Sciences Private Capital Team Targeting Investments in Innovative Healthcare Companies

Healthcare

/PRNewswire/ -- J.P. Morgan Asset Management today announced the launch of a new life sciences private equity team, Life Sciences Private Capital. The new team...

Read article

insights.omnia-health.com

Leveraging nanotechnology to transform the disinfection industry

Healthcare

Co-founders of Kismet Technologies, Christina Drake and Shari Costantini, discuss how NanoRad, one of their flagship products, uses targeted application to kill a wide range of bacteria and viruses.

Read article

www.bain.com

2022 Healthcare Provider IT Report: Post-Pandemic Investment Priorities

Healthcare

As healthcare providers enter a new period of disruption, their software investment priorities present opportunities for vendors and investors.

Read article

Thematics

thematic

Healthcare

20.12.22

Cell and gene therapies

thematic

Healthcare

28.11.22

Drug delivery platforms

thematic

Healthcare

07.11.22

Oncology ABCs (part three) – thinking outside the box in women’s cancer

thematic

Healthcare

01.11.22

Neuroscience comeback

thematic

Consumer

05.10.22

IPO apocalypse

thematic

Healthcare

03.10.22

Oncology ABCs (part two) – vaccines: niche no longer

thematic

TMT

10.08.22

ESG, moving beyond the box tick

thematic

Healthcare

01.07.22

Oncology ABCs (part one) – a small-cap biopharma prospectus series

Equities

Equities by Sector

Sectors

Thematics

Latest

Why is gold hitting new highs?

Saba Capital campaign – Your vote matters

Market outlook: What lies ahead in 2025

Audiovisual

Latest

Uncovering Trusts – Saba Capital Campaign

Uncovering Trusts – Finsbury Growth & Income Trust (FGT)

Take on Trusts – December 2024

About Edison

About Edison

Careers

Healthcare

Chosa

16.42%

Healthcare Insights

VolitionRx – Decoding the DNA of cancer

Outlook for 2024: Life sciences – where has the conviction gone?

Healthcare-focused trusts: A sector on the mend

Latest

Herantis Pharma — Potential disease-modifier for PD

Newron Pharmaceuticals — Spotlight on evenamide following licensing deals

Immix Biopharma — Shifting the ALA treatment paradigm with CAR-T

Mendus — Regulatory endorsement supports vididencel focus

An update on OpGen: Deals, expansion and revenues

Volition: Views from the sharp end

Incannex Healthcare: Data opens path to treat anxiety

February 2023 Edition of Edison Healthcare Insight

VolitionRx: Commercializing the Nu.Q Vet Cancer Test: Webinar

Encouraging top-line data from Unyvero urinary tract infection (UTI) panel

Equities

Nykode Therapeutics (NYKD)

NOK2.62

Nykode Therapeutics — Repositioned to streamline clinical progress

See morecontent on

OpGen (OPGN)

USD1.16

OpGen — Cash concerns dampen active Q2

OpGen — FIND collaboration advances to development

OpGen — Feasibility milestone from FIND collaboration

See morecontent on

Oryzon Genomics (ORY)

EUR1.47

Oryzon Genomics — Q3 results recap key upcoming inflection points

Oryzon Genomics — FDA aligns on Phase III BPD plans

Oryzon Genomics — Final PORTICO data reaffirms potential in BPD

See morecontent on

OSE Immunotherapeutics (OSE)

EUR6.56

OSE Immunotherapeutics — Full Lusvertikimab results reflect potential in UC

OSE Immunotherapeutics — Riding the H124 tailwinds

OSE Immunotherapeutics — Tedopi registrational study commences

See morecontent on

Percheron Therapeutics (PER)

GBP0.00

Recce Pharmaceuticals (RCE)

AUD0.48

Recce Pharmaceuticals — BPOM clearance to start Phase III R327G study

Recce Pharmaceuticals — Topical R327G approaching pivotal stages

Recce Pharmaceuticals — Taking a closer look at diabetic foot infections

See morecontent on

Sareum Holdings (SAR)

GBP0.23

Sareum Holdings — SDC-1801 prepping to enter Phase II

Freelancer — Escrow drives strong volume growth in Q324

Sareum Holdings — New funding extends runway to Phase II

See morecontent on

SIGA Technologies (SIGA)

USD6.32

SIGA Technologies — Strong order book moving into Q424

SIGA Technologies — TPOXX chalks up another DoD contract win

SIGA Technologies — PALM 007 data warrant a closer look in mpox

See morecontent on

Curated by Edison

The Next Step for AI in Biology Is to Predict How Proteins Behave in the Body

The Cost of Sequencing a Human Genome

See more
content on

See more
content on

See more
content on

See more
content on

See more
content on

See more
content on

See more
content on